← Open Payments lookup

CRISTIE FAIRCLOTH: Open Payments

NPI 1487800314 · CHARLOTTE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$586 in 29 payments from 11 companies in 2025. Trend: 2023 $454 · 2024 $686 · 2025 $586

Food & beverage: $586
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.10$195
E.R. Squibb & Sons, L.L.C.4$94
Neurocrine BioSciences, Inc.2$50
Teva Pharmaceuticals USA, Inc.2$42
ABBVIE INC.2$39
Neos Therapeutics, LP2$39
Takeda Pharmaceuticals U.S.A., Inc.2$34
Janssen Pharmaceuticals, Inc1$28
Alkermes, Inc.2$28
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$22

Products named: REXULTI, COBENFY, INGREZZA, AUSTEDO XR, VRAYLAR, Adzenys XR-ODT, TRINTELLIX, SPRAVATO.

Industry payments across NC — which companies pay providers there.